1Q4X
Crystal Structure of Human Thyroid Hormone Receptor beta LBD in complex with specific agonist GC-24
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | ALS BEAMLINE 8.3.1 |
| Synchrotron site | ALS |
| Beamline | 8.3.1 |
| Temperature [K] | 100 |
| Detector technology | CCD |
| Collection date | 2002-02-02 |
| Detector | ADSC QUANTUM 4 |
| Wavelength(s) | 1.127 |
| Spacegroup name | P 65 2 2 |
| Unit cell lengths | 56.570, 56.570, 390.050 |
| Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
| Resolution | 24.470 - 2.800 |
| R-factor | 0.228 |
| Rwork | 0.216 |
| R-free | 0.26400 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | Human Thyroid Hormone Receptor beta in complex with agonist GC-1; the crystal structure was solved in our lab but not deposited at the PDB |
| RMSD bond length | 0.011 |
| RMSD bond angle | 21.700 |
| Data reduction software | DENZO |
| Data scaling software | SCALEPACK |
| Phasing software | CNS |
| Refinement software | CNS |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 24.470 | 2.980 |
| High resolution limit [Å] | 2.800 | 2.800 |
| Rmerge | 0.069 | 0.161 * |
| Total number of observations | 113019 * | |
| Number of reflections | 9368 | |
| <I/σ(I)> | 15.8 | |
| Completeness [%] | 93.0 | 81.5 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 4.9 | 4 * | PEG 3350, sodium acetate, glucose, cymal-2, pH 4.9, VAPOR DIFFUSION, SITTING DROP, temperature 291.0K |
Crystallization Reagents in Literatures
| ID | crystal ID | solution | reagent name | concentration (unit) | details |
| 1 | 1 | drop | protein | 10.5 (mg/l) | |
| 2 | 1 | reservoir | sodium acetate | 0.1 (M) | |
| 3 | 1 | reservoir | PEG3350 | 10 (%) | |
| 4 | 1 | reservoir | ammonium sulfate | 0.15 (M) |






